Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

New treatment option for Gaucher's disease patients in Germany

Jan. 20, 1999

Nitromethyl ketones from Merck KGaA protect against diabetic complications

Jan. 20, 1999

Long-term beneficial effects of orlistat reported in JAMA

Jan. 20, 1999

Takeda submits NDA for type II diabetes treatment

Jan. 19, 1999

Besins Iscovesco provides funds to speed development of Andractim

Jan. 19, 1999

Knoll's antiobesity drug Reductil approved in Germany

Jan. 19, 1999

New indication approved for Livial, a tissue-specific treatment for menopausal symptoms

Jan. 19, 1999

Cyanoenamines as potassium channel modulators

Jan. 19, 1999

Warner-Lambert updates U.S. status of Rezulin

Jan. 18, 1999

Novel antidiabetic agents in development at Novo Nordisk

Jan. 18, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...